Peck, Carl
128  results:
Search for persons X
?
3

Determination of the starting dose in the first-in-human cl..:

Suh, Hoon Young ; Peck, Carl ; Yu, Kyung-Sang.
Drug Design, Development and Therapy.  10 (2016)  - p. 4005-4016 , 2016
 
?
 
?
5

Efficacy of 17α-ethynylestradiol-3-sulfate for severe hemor..:

Miller, Matthew ; Keith, James ; Berman, Jonathan...
Journal of Trauma and Acute Care Surgery.  76 (2014)  6 - p. 1409-1416 , 2014
 
?
6

Physiologically-Based Pharmacokinetics in Drug Development ..:

Rowland, Malcolm ; Peck, Carl ; Tucker, Geoffrey
Annual Review of Pharmacology and Toxicology.  51 (2011)  1 - p. 45-73 , 2011
 
?
7

Current issues relating to drug safety especially with rega..:

Rolan, Paul ; Danhof, Meindert ; Stanski, Donald.
European Journal of Pharmaceutical Sciences.  30 (2007)  2 - p. 107-112 , 2007
 
?
9

Postmarketing drug dosage changes of 499 FDA‐approved new m..:

Cross, James ; Lee, Howard ; Westelinck, Agnes...
Pharmacoepidemiology and Drug Safety.  11 (2002)  6 - p. 439-446 , 2002
 
?
12

Impact of Clinical Pharmacology on the Modernization of Dru..:

, In: AAPS Introductions in the Pharmaceutical Sciences; Advances in Pharmacokinetics and Pharmacodynamics,
Zhao, Liang ; Peck, Carl C. - p. 165-202 , 2023
 
?
13

Disease progress models:

, In: Atkinson's Principles of Clinical Pharmacology,
 
?
14

Contributors:

, In: Atkinson's Principles of Clinical Pharmacology,
 
?
15

Regulatory Perspectives : Where We Came from, Where Are We ..:

Peck, Carl C.
Acta Pharmaceutica Hungarica.  91 (2021)  3-4 - p. 91-92 , 2021
 
1-15
Related subjects